| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 26.95% | JP Morgan | $122 → $105 | Maintains | Overweight |
| 11/10/2023 | 39.04% | Benchmark | $133 → $115 | Maintains | Buy |
| 11/09/2023 | 40.25% | Stifel | $123 → $116 | Maintains | Buy |
| 11/09/2023 | 5.19% | RBC Capital | $106 → $87 | Maintains | Sector Perform |
| 11/09/2023 | 12.44% | Stephens & Co. | $130 → $93 | Downgrades | Overweight → Equal-Weight |
| 09/19/2023 | 51.13% | Wedbush | → $125 | Reiterates | Outperform → Outperform |
| 08/11/2023 | 28.16% | RBC Capital | $105 → $106 | Maintains | Sector Perform |
| 08/10/2023 | 60.8% | Benchmark | $113 → $133 | Maintains | Buy |
| 08/10/2023 | 57.18% | Stephens & Co. | $110 → $130 | Maintains | Overweight |
| 05/10/2023 | 32.99% | Stephens & Co. | $105 → $110 | Maintains | Overweight |
| 05/10/2023 | 26.95% | RBC Capital | $95 → $105 | Maintains | Sector Perform |
| 05/10/2023 | 39.04% | Baird | $110 → $115 | Maintains | Outperform |
| 05/09/2023 | 39.04% | Wedbush | → $115 | Reiterates | → Outperform |
| 02/24/2023 | 32.99% | Baird | $108 → $110 | Maintains | Outperform |
| 01/13/2023 | 7.6% | RBC Capital | $91 → $89 | Downgrades | Outperform → Sector Perform |
| 01/11/2023 | 35.41% | Deutsche Bank | $90 → $112 | Maintains | Buy |
| 12/19/2022 | 18.49% | Stifel | $97 → $98 | Maintains | Buy |
| 11/09/2022 | 8.81% | Stephens & Co. | $110 → $90 | Maintains | Overweight |
| 11/09/2022 | 10.02% | RBC Capital | $99 → $91 | Maintains | Outperform |
| 10/20/2022 | 19.7% | Deutsche Bank | $135 → $99 | Maintains | Buy |
| 08/18/2022 | 63.22% | Deutsche Bank | → $135 | Initiates Coverage On | → Buy |
| 08/10/2022 | 19.7% | RBC Capital | $90 → $99 | Maintains | Outperform |
| 07/15/2022 | 12.44% | JP Morgan | $110 → $93 | Maintains | Overweight |
| 06/29/2022 | 30.58% | Baird | $105 → $108 | Maintains | Outperform |
| 04/20/2022 | 8.81% | JP Morgan | $110 → $90 | Maintains | Overweight |
| 03/30/2022 | 32.99% | JP Morgan | $130 → $110 | Maintains | Overweight |
| 02/23/2022 | 71.68% | RBC Capital | $153 → $142 | Maintains | Outperform |
| 11/10/2021 | 86.19% | RBC Capital | $144 → $154 | Maintains | Outperform |
| 03/22/2021 | 63.22% | Baird | → $135 | Upgrades | Neutral → Outperform |
| 02/09/2021 | 63.22% | Wedbush | $108 → $135 | Maintains | Outperform |
| 11/13/2020 | — | Wedbush | Upgrades | Neutral → Outperform | |
| 10/20/2020 | 30.58% | Baird | $92 → $108 | Maintains | Neutral |
| 10/05/2020 | 51.13% | Benchmark | $100 → $125 | Maintains | Buy |
| 08/05/2020 | 20.9% | Benchmark | $86 → $100 | Maintains | Buy |
| 07/20/2020 | — | Northcoast Research | Downgrades | Buy → Neutral | |
| 06/29/2020 | -12.95% | Baird | $64 → $72 | Maintains | Neutral |
| 06/18/2020 | -2.07% | Benchmark | $77 → $81 | Maintains | Buy |
| 06/11/2020 | -9.32% | Wedbush | → $75 | Downgrades | Outperform → Neutral |
| 05/08/2020 | 14.86% | Nomura | $69 → $95 | Maintains | Buy |
| 05/07/2020 | -22.62% | Baird | $55 → $64 | Maintains | Neutral |
| 04/17/2020 | -16.58% | Nomura | $57 → $69 | Maintains | Buy |
| 04/16/2020 | — | Baird | Downgrades | Outperform → Neutral | |
| 04/01/2020 | -31.08% | Nomura | $85 → $57 | Maintains | Buy |
| 03/31/2020 | -28.67% | JP Morgan | $100 → $59 | Maintains | Overweight |
| 03/30/2020 | -0.86% | Wedbush | $95 → $82 | Maintains | Outperform |
| 03/16/2020 | -9.32% | RBC Capital | $85 → $75 | Upgrades | Sector Perform → Outperform |
| 03/11/2020 | 14.86% | Wedbush | $78 → $95 | Upgrades | Neutral → Outperform |
| 02/21/2020 | 37.83% | Stephens & Co. | $70 → $114 | Upgrades | Equal-Weight → Overweight |
| 02/20/2020 | 14.86% | Baird | $88 → $95 | Maintains | Outperform |
| 02/05/2020 | — | Benchmark | Initiates Coverage On | → Buy | |
| 11/27/2019 | — | Northcoast Research | Upgrades | Neutral → Buy | |
| 11/06/2019 | -12.95% | Baird | $65 → $72 | Maintains | Outperform |
| 11/06/2019 | -3.28% | Stifel | $50 → $80 | Upgrades | Hold → Buy |
| 11/06/2019 | -25.04% | RBC Capital | → $62 | Downgrades | Outperform → Sector Perform |
| 03/15/2019 | -26.25% | Seaport Global | → $61 | Initiates Coverage On | → Buy |
| 02/01/2019 | -32.29% | B. Riley Securities | $66 → $56 | Downgrades | Buy → Neutral |
| 12/18/2018 | -39.55% | Wedbush | $60 → $50 | Maintains | Neutral |
| 11/13/2018 | -27.46% | Wedbush | $67 → $60 | Maintains | Neutral |
What is the target price for Masonite International (DOOR)?
The latest price target for Masonite International (NYSE: DOOR) was reported by JP Morgan on November 13, 2023. The analyst firm set a price target for $105.00 expecting DOOR to rise to within 12 months (a possible 26.95% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Masonite International (DOOR)?
The latest analyst rating for Masonite International (NYSE: DOOR) was provided by JP Morgan, and Masonite International maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Masonite International (DOOR)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Masonite International, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Masonite International was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Masonite International (DOOR) correct?
While ratings are subjective and will change, the latest Masonite International (DOOR) rating was a maintained with a price target of $122.00 to $105.00. The current price Masonite International (DOOR) is trading at is $82.71, which is out of the analyst's predicted range.